FSDA Raids Drug Market In Muzaffarnagar

Muzaffarnagar : In Muzaffarnagar, a raid was conducted on the complaint of drug business in the Zilla Parishad market. On Friday, the team of Drug Inspector under the leadership of Assistant Commissioner(Drugs) Shashi Mohan Gupta started a close investigation on various drug agencies. The raid created a stir in the Zilla Parishad market.

As soon as the teams of the Drug Administration Department reached the Zilla Parishad market on Friday, panic spread among the drug agency owners. Assistant Commissioner(Drugs) Shashi Mohan Gupta said that teams of drug inspectors of Saharanpur, Muzaffarnagar and Shamli are being formed and various medical agencies of Zilla Parishad are being investigated.

He said that during the investigation, the supply of sub-standard, spurious and banned medicines and irregularities are also being investigated. Told that the team includes Drug Inspector Pawan Kumar Shakya of Muzaffarnagar, Luv Kush Prasad of Saharanpur and Nidhi Pandey of Shamli.

Medicines are supplied from the Zilla Parishad market of Muzaffarnagar to western Uttar Pradesh and neighboring states. Due to the large market of medicines, there is a huge crowd of medicine buyers in the Zilla Parishad all the time.

For a few days, the Drug Administration Department was receiving complaints about the supply of drugs from the Zilla Parishad market in the neighboring districts. If sources are to be believed, after the complaint made at the government level, a team of drug inspectors under the leadership of Assistant Commissioner(Drugs) Shashi Mohan Gupta has been sent for raids.

The team inspected at Pooja Medicos, Basant Pharmaceutical, Jain Pharma, Sandeep Medical Agency, Unique Pharma, Chopra Medical Agency, Mars Medical Agency, Madhav Medical Agency, Deep Medical Agency, Lucky Medical Agency, Kaushik Medical Agency and Dhaka Medicos in Zilla Parishad.

  • Related Posts

    Unapproved drops for dry eyes pose risks: Govt

    NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Unapproved drops for dry eyes pose risks: Govt

    Unapproved drops for dry eyes pose risks: Govt

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

    Govt highlights multi-layer framework to curb misleading advertisements

    Govt highlights multi-layer framework to curb misleading advertisements

    Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

    Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

    Study finds rising resistance to a last-resort antibiotic in Africa

    Study finds rising resistance to a last-resort antibiotic in Africa